Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury

Journal of the American Society of Nephrology

Volumn 23, Issue 7, 2012, Pages 1198-1209

  Ogawa, Yoshihisa ^a   Mukoyama, Masashi ^a   Yokoi, Hideki ^a   Kasahara, Masato ^a   Mori, Kiyoshi ^a   Kato, Yukiko ^a   Kuwabara, Takashige ^a   Imamaki, Hirotaka ^a   Kawanishi, Tomoko ^a   Koga, Kenichi ^a   Ishii, Akira ^a   Tokudome, Takeshi ^b   Kishimoto, Ichiro ^c   Sugawara, Akira ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Cerebral and Cardiovascular Center Research Institute   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GUANYLATE CYCLASE; HYDRALAZINE; MITOGEN ACTIVATED PROTEIN KINASE; NATRIURETIC PEPTIDE RECEPTOR A; OLMESARTAN; SPIRONOLACTONE; TEMPOL;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HIGH SODIUM INTAKE; HYPERTENSION; KIDNEY INJURY; KNOCKOUT MOUSE; MALE; MESANGIUM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WILD TYPE;

EID: 84863532164     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011100985     Document Type: Article

References (47)

1. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G: Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33: 261-266, 1999 (Pubitemid 29072226)
2. Schrier RW, Masoumi A, Elhassan E: Aldosterone: Role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol 5: 1132-1140, 2010
3. Ribstein J, Du Cailar G, Fesler P, Mimran A: Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 16: 1320-1325, 2005 (Pubitemid 41716516)
4. Greene EL, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98: 1063-1068, 1996 (Pubitemid 26293326)
5. Klar J, Vitzthum H, Kurtz A: Aldosterone enhances renin gene expression in juxtaglomerular cells. Am J Physiol Renal Physiol 286: F349-F355, 2004 (Pubitemid 38141679)
6. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Kuwahara K, Saito Y, Nakao K, Ogawa H: Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104: 137-139, 2001 (Pubitemid 32655827)
7. Briet M, Schiffrin EL: Aldosterone: Effects on the kidney and cardiovascular system. Nat Rev Nephrol 6: 261-273, 2010
8. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43: 841-848, 2004 (Pubitemid 38405598)
9. Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S: Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J Am Soc Nephrol 16: 2296-2305, 2005 (Pubitemid 41725047)
10. Mundel P, Reiser J: Proteinuria: An enzymatic disease of the podocyte? Kidney Int 77: 571-580, 2010
11. Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T: Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 47: 1084-1093, 2006 (Pubitemid 44289165)
12. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T: Podocyte as the target for aldosterone: Roles of oxidative stress and Sgk1. Hypertension 49: 355-364, 2007 (Pubitemid 46143013)
13. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T: Modification of mineralocorticoid receptor function by Rac1GTPase: Implication in proteinuric kidney disease. Nat Med 14: 1370-1376, 2008
14. Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens 10: 907-912, 1992
15. Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Nishimura K, Obata K, Yasue H, Ban T, Imura H: Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. J Clin Invest 81: 1962-1970, 1988
16. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87: 1402-1412, 1991
17. Potter LR, Abbey-Hosch S, Dickey DM: Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72, 2006 (Pubitemid 43228238)
18. Ritter D, Dean AD, Gluck SL, Greenwald JE: Natriuretic peptide receptors A and B have different cellular distributions in rat kidney. Kidney Int 48: 5758-5766, 1995
19. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68, 1995
20. Kishimoto I, Rossi K, Garbers DL: A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98: 2703-2706, 2001 (Pubitemid 32209546)
21. Kishimoto I, Dubois SK, Garbers DL: The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: Acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93: 6215-6219, 1996 (Pubitemid 26190830)
22. Conger JD, Falk SA, Hammond WS: Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40: 21-28, 1991
23. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK: Atrial natriuretic peptide for management of acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol 4: 261-272, 2009
24. Kasahara M, Mukoyama M, Sugawara A, Makino H, Suganami T, Ogawa Y, Nakagawa M, Yahata K, Goto M, Ishibashi R, Tamura N, Tanaka I, Nakao K: Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J Am Soc Nephrol 11: 1691-1701, 2000
25. Suganami T, Mukoyama M, Sugawara A, Mori K, Nagae T, Kasahara M, Yahata K, Makino H, Fujinaga Y, Ogawa Y, Tanaka I, Nakao K: Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol 12: 2652-2663, 2001 (Pubitemid 33115412)
26. Makino H, Mukoyama M, Mori K, Suganami T, Kasahara M, Yahata K, Nagae T, Yokoi H, Sawai K, Ogawa Y, Suga S, Yoshimasa Y, Sugawara A, Tanaka I, Nakao K: Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia 49: 2514-2524, 2006 (Pubitemid 44359114)
27. Opgenorth TJ, Burnett JC Jr, Granger JP, Scriven TA: Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney. Am J Physiol 250: F798-F801, 1986
28. Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H, Ogawa H: Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 107: 807-810, 2003 (Pubitemid 36241036)
29. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007 (Pubitemid 46209993)
30. Vellaichamy E, Zhao D, Somanna N, Pandey KN: Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: Role in cardiac hypertrophy. Physiol Genomics 31: 193-202, 2007 (Pubitemid 350014397)
31. Hoffmann S, Podlich D, Hähnel B, Kriz W, Gretz N: Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15: 1475-1487, 2004 (Pubitemid 38679672)
32. Crowley SD, Vasievich MP, Ruiz P, Gould SK, Parsons KK, Pazmino AK, Facemire C, Chen BJ, Kim HS, Tran TT, Pisetsky DS, Barisoni L, Prieto-Carrasquero MC, Jeansson M, Foster MH, Coffman TM: Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest 119: 943-953, 2009
33. Golos M, Lewko B, Bryl E, Witkowski JM, Dubaniewicz A, Olszewska A, Latawiec E, Angielski S, Stepinski J: Effect of angiotensin II on ANP-dependent guanylyl cyclase activity in cultured mouse and rat podocytes. Kidney Blood Press Res 25: 296-302, 2002 (Pubitemid 35356750)
34. Baldini PM, De Vito P, D'aquilio F, Vismara D, Zalfa F, Bagni C, Fiaccavento R, Di Nardo P: Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth. Mol Cell Biochem 272: 19-28, 2005 (Pubitemid 40867361)
35. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL: Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 276: G1137-G1144, 1999 (Pubitemid 29251912)
36. Modlinger PS, Wilcox CS, Aslam S: Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24: 354-365, 2004 (Pubitemid 38900635)
37. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG; BEAM Study Investigators: Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365: 327-336, 2011
38. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, Zhang DD: The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59: 850-860, 2010
39. Thalhamer T, McGrath MA, Harnett MM: MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 47: 409-414, 2008
40. Kim EK, Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405, 2010
41. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K: Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16: 2690-2701, 2005
42. Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, Kamiie J, Fujinaka H, Oite T, Yamamoto T: Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 161: 1597-1606, 2002 (Pubitemid 35265520)
43. Stephens RS, Rentsendorj O, Servinsky LE, Moldobaeva A, Damico R, Pearse DB: cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells by a protein kinase G-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 299: L323-L333, 2010
44. Takahashi N, Saito Y, Kuwahara K, Harada M, Kishimoto I, Ogawa Y, Kawakami R, Nakagawa Y, Nakanishi M, Nakao K: Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation. Hypertens Res 26: 847-853, 2003 (Pubitemid 37406954)
45. Schrier RW, Abraham WT: Hormones and hemodynamics in heart failure. N Engl J Med 341: 577-585, 1999 (Pubitemid 29384167)
46. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, Yoshioka T, Saito Y, Ogawa Y, Kuwabara T, Sugawara A, Nakao K: Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 73: 446-455, 2008 (Pubitemid 351186294)
47. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15: 1430-1440, 2004 (Pubitemid 38679668)